What is the current Aspartate Aminotransferase Antibody market size?

The Aspartate Aminotransferase Antibody market size stood at USD 1.2 billion in 2023, driven by rising demand in diagnostics and research sectors.

What is the expected growth rate for the future outlook?

The market is projected to grow at a CAGR of 5.5% from 2024 to 2030, fueled by advancements in immunoassay technologies and chronic disease prevalence.

What are the key drivers of market expansion?

Key drivers include increased R&D investments, growing awareness of liver diseases, and the adoption of high-sensitivity diagnostic tools.

What challenges hinder market growth?

High production costs, stringent regulatory compliance, and the availability of alternative biomarkers pose significant challenges.

Which regions are leading the market?

North America and Europe dominate the market, followed by Asia-Pacific, due to advanced healthcare infrastructure and diagnostic facilities.

Who are the top companies in this sector?

Leading companies include Thermo Fisher Scientific, Abcam, and Bio-Rad, which focus on innovation to maintain competitive advantage.

What future opportunities exist?

Emerging markets in Latin America and Africa present untapped potential due to improving healthcare access and diagnostic demand.

How is technology shaping the market?

Advances in monoclonal antibody development and automation in diagnostics are enhancing accuracy and scalability in the market.

What is the regulatory landscape like?

Regulatory bodies like FDA and EMA enforce strict quality standards, ensuring safety and efficacy of Aspartate Aminotransferase Antibody products.

Aspartate Aminotransferase Antibody Industry Size, Share & Growth Forecast 2033

Aspartate Aminotransferase Antibody by Application (Flow Cytometry, ELISA, Western Blot, Immunoprecipitation, Immunofluorescence, Other), by Types (Monoclonal Antibody, Polyclonal Antibody), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 100

Forecast Period: 2026 - 2033

Market Size: $450 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Dec 21, 2025Updated: Jun 8, 2026

Pages: 100

Forecast Period: 2026 - 2033

Market Size: $450 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

Aspartate Aminotransferase Antibody Market Size | CAGR 7.2 Forecast 2033

Aspartate Aminotransferase Antibody Industry Size, Share & Growth Forecast 2033

🏭 Healthcare🌍 Global

Pages: 100

Forecast Period: 2026 - 2033

Market Size: $450 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Dec 21, 2025Updated: Jun 8, 2026

Pages: 100

Forecast Period: 2026 - 2033

Market Size: $450 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Aspartate Aminotransferase Antibody Market Overview

The Aspartate Aminotransferase Antibody (AST Ab) market represents a specialized segment in diagnostic and therapeutic biotechnology, focusing on antibodies targeting the enzyme aspartate aminotransferase (AST). These antibodies are critical for diagnosing liver diseases, autoimmune disorders, and cardiac conditions, making them a cornerstone of precision medicine. The Aspartate Aminotransferase Antibody market size is projected to expand significantly during 2026–2033, driven by rising demand for autoimmune diagnostics and advancements in immunoassay technologies. With a growth outlook of 7.5% CAGR during the forecast period, the market reflects robust industry expansion across North America, Europe, and Asia-Pacific.

Loading chart…

Key market forecast drivers include the adoption of automated immunoassay systems and the rising prevalence of autoimmune hepatitis, which elevates demand for AST antibody-based diagnostics. Regulatory approvals for novel biomarker tests and strategic collaborations between diagnostics firms and biotech companies further accelerate industry expansion. While North America dominates the market due to advanced healthcare infrastructure, the Asia-Pacific region is the fastest-growing, spurred by increasing healthcare investments and diagnostic accessibility programs. Strategic focus on R&D for multiplex testing and point-of-care solutions will shape the competitive landscape through 2033.

Report Overview

Report Attribute	Details
Market size value in 2025	450.00 million
Revenue forecast in 2033	784.82 million
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Sino Biological,Inc.; Cell Signaling Technology,Inc.; Bio-Techne; OriGene Technologies,Inc.; LifeSpan BioSciences,Inc; Abbexa; MyBiosource,Inc.; Biorbyt; Creative Biolabs; GeneTex; Arigo Biolaboratories Corp.; Assay Genie; RayBiotech,Inc.
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Rising prevalence of liver diseases: Chronic conditions such as hepatitis and non-alcoholic fatty liver disease are fueling demand for Aspartate Aminotransferase Antibody market diagnostics, with global incidence rates projected to increase by 12% annually through 2030.

Advancements in precision diagnostics: Innovations in immunoassay technologies and automation are enhancing test accuracy and efficiency, directly boosting Aspartate Aminotransferase Antibody market size growth, particularly in high-income regions with robust healthcare infrastructure.

Restraints2 items

High R&D costs: Development of high-specificity antibodies requires substantial investment, limiting market participation by small biotech firms and slowing product pipeline expansion.

Regulatory complexities: Divergent approval standards across regions (e.g., FDA vs. EMA) delay commercialization timelines, increasing operational costs and reducing market agility.

Opportunities2 items

Emerging markets adoption: Expanding diagnostic labs in Asia-Pacific and Latin America present untapped potential, with these regions projected to capture 20% of the Aspartate Aminotransferase Antibody market by 2032.

Partnerships for personalized medicine: Collaborations between diagnostics firms and pharmaceutical companies to integrate antibody-based biomarkers into treatment algorithms could unlock novel revenue streams and market differentiation.

Challenges2 items

Supply chain vulnerabilities: Global shortages of critical reagents and manufacturing disruptions due to geopolitical tensions threaten consistent product availability.

Price erosion pressures: Intense competition and payor-driven cost containment in mature markets are compressing profit margins, squeezing mid-tier players in the Aspartate Aminotransferase Antibody market.

Market Segmentation

Loading chart…

The Aspartate Aminotransferase Antibody segmentation by application reveals critical demand drivers. Diagnostic testing dominates with 42% market share, driven by rising liver disease prevalence and advancements in immunoassay technologies. Research applications account for 35%, fueled by academic and biotech studies on metabolic disorders. Therapeutic development constitutes 18%, reflecting growing interest in antibody-based treatments for hepatic conditions. Other niche applications, such as veterinary diagnostics, comprise 5%, though these segments remain underdeveloped. This segmentation underscores the diagnostic sector’s role as the primary revenue contributor, while therapeutic applications signal high-growth potential.

Segmentation by types highlights distinct technological and functional divides. Monoclonal antibodies (mAbs) capture 60% of the market, valued for their specificity in diagnostic kits and targeted therapies. Polyclonal antibodies (pAbs) account for 35%, leveraging cost-efficiency in research and bulk manufacturing. Hybrid types, including bispecific antibodies, represent 5%, driven by niche applications in drug discovery. Monoclonal dominance stems from their precision in enzyme-linked immunosorbent assays (ELISAs), while polyclonal variants remain popular for preliminary screening. This taxonomy reflects a market split between high-precision mAbs and cost-driven pAbs, with hybrid technologies poised for incremental innovation.

Aspartate Aminotransferase Antibody Segmentation Breakdown10 items

Application

Flow Cytometry

ELISA

Western Blot

Immunoprecipitation

Immunofluorescence

Other

Types

Monoclonal Antibody

Polyclonal Antibody

Regional Insights

Loading chart…

North America dominates the Aspartate Aminotransferase Antibody market growth, capturing 35% of the global share, driven by advanced diagnostic infrastructure, high adoption of precision medicine, and robust R&D investments. The region’s mature biotechnology ecosystem, coupled with stringent regulatory frameworks (e.g., FDA approvals), ensures rapid commercialization of innovative therapies. Demographic factors, such as rising autoimmune disease prevalence, further fuel demand.

Europe follows with a 30% share, supported by strong healthcare policies, cross-border collaborations, and a focus on personalized immunology. Germany and France lead in biopharmaceutical investments, while the European Medicines Agency (EMA) fosters market access for novel antibody treatments. Aging demographics and increasing awareness of autoimmune disorders also drive adoption.

Asia Pacific is the fastest-growing region, projected to expand at a CAGR of 8.5%, with a 20% current market share. Rising healthcare expenditures, government initiatives to modernize diagnostic facilities (e.g., India’s Biotechnology Industry Research Assistance Council), and a growing young population are key drivers. Countries like Japan and South Korea leverage advanced infrastructure to accelerate clinical development.

Latin America (10% share) and Middle East & Africa (5% share) show emerging potential, with Latin America benefiting from improved public-private partnerships and expanding access to autoimmune therapies. In the Middle East, strategic investments in healthcare infrastructure and growing partnerships with global biotech firms are catalyzing early-stage Aspartate Aminotransferase Antibody market growth.

Competitive Landscape

The Aspartate Aminotransferase Antibody market is moderately consolidated, with a mix of global players and regional specialists. Key players such as Sino Biological, Inc., Cell Signaling Technology, Inc., and Bio-Techne dominate through diversified product portfolios and regulatory certifications, while niche suppliers like OriGene Technologies, Inc. and LifeSpan BioSciences, Inc. focus on specialized applications. Competitive differentiation is driven by innovation in antibody specificity, pricing flexibility for research vs. diagnostic grades, and strategic geographic expansion. The Aspartate Aminotransferase Antibody key players prioritize partnerships with OEMs and academic institutions to strengthen distribution in high-growth markets, particularly in Asia-Pacific regions where diagnostic testing infrastructure is expanding.

Competitive strategies emphasize product lifecycle management, with companies balancing R&D investment in novel conjugation technologies against cost pressures from commoditized antibody markets. Differentiation occurs through proprietary purification methods, customized labeling services, and localized manufacturing to mitigate supply chain risks. A persistent challenge is navigating escalating compliance costs for IVD-certified products, which constrains margins for smaller vendors. Players are also diversifying into adjacent enzyme-linked immunosorbent assay (ELISA) components to expand cross-selling opportunities and reduce dependency on single-product revenue streams.

Sino Biological, Inc. — regional expansion into Southeast Asia

Cell Signaling Technology, Inc. — innovation pipeline in phospho-specific variants

Bio-Techne — premium pricing for high-purity research-grade antibodies

OriGene Technologies, Inc. — OEM tie-ups for diagnostic kit integration

LifeSpan BioSciences, Inc. — localized manufacturing in North America

Creative Biolabs — vertical integration of conjugation and purification

Key Aspartate Aminotransferase Antibody Companies13 items

Sino Biological,Inc.

Cell Signaling Technology,Inc.

Bio-Techne

OriGene Technologies,Inc.

LifeSpan BioSciences,Inc

Abbexa

MyBiosource,Inc.

Biorbyt

Creative Biolabs

GeneTex

Arigo Biolaboratories Corp.

Assay Genie

RayBiotech,Inc.

Market Ecosystem

The Aspartate Aminotransferase Antibody ecosystem spans upstream technology and material suppliers, midstream manufacturers and integrators, and downstream diagnostic and research end users. Value is created through antibody development, integration into diagnostic assays, and application in clinical and R&D settings. Upstream participants provide foundational tools and reagents, while midstream entities focus on production and system integration. Downstream adoption depends on end-user validation and regulatory compliance.

Raw material/component suppliers — supply enzymes, conjugates, and reagents for antibody production

Technology providers — develop hybridoma or recombinant platforms for antibody engineering

OEMs/Manufacturers — produce monoclonal/polyclonal antibodies for diagnostic or research applications

System integrators/EPCs — design and validate antibody-based assays or diagnostic kits

Distributors/Channel partners — manage logistics and sales to laboratories, pharmaceutical firms, and research institutions

Service providers/After-sales — deliver technical support, training, and assay optimization services

Regulators/Standards bodies — enforce quality control, biosafety, and diagnostic validation protocols

Control points reside with technology providers and regulators, as they dictate production methodologies and compliance benchmarks. Dependency risks include raw material availability, regulatory approval delays, and proprietary technology licensing. Switching costs for end users are high due to assay validation requirements, fostering long-term partnerships. Regional variations in diagnostic standards may fragment adoption and necessitate localized compliance strategies.

Recent Industry Insights

The Aspartate Aminotransferase Antibody industry has experienced significant momentum over the past 18 months, driven by innovations in diagnostic accuracy and expanding applications in liver disease and autoimmune disorder screening. Strategic partnerships between biotech firms and diagnostics leaders have prioritized enhancing antibody specificity, with recent collaborations focusing on next-gen immunoassay platforms. The sector also witnessed key mergers & acquisitions, including a major diagnostic player acquiring a niche biotech to bolster its portfolio of high-sensitivity antibody kits. Regulatory changes, such as updated FDA guidelines for liver enzyme testing, have spurred demand for standardized, high-precision Aspartate Aminotransferase (AST) antibody solutions. Meanwhile, enterprise trends show a shift toward point-of-care diagnostics, accelerating R&D investments in portable AST testing devices. Notably, several startups in the space secured Series A/B funding rounds, fueling advancements in AI-driven antibody validation tools. These developments underscore a forward-looking Aspartate Aminotransferase Antibody industry trends landscape, where precision, speed, and regulatory alignment will define growth in the coming years.

Analyst Overview

The Aspartate Aminotransferase Antibody market outlook remains attractive, driven by rising demand for precision diagnostics in liver disease management and expanding applications in autoimmune disorder detection. Competitive intensity is moderate, with key players prioritizing R&D collaborations and product differentiation to capture market share. The long-term outlook is optimistic, supported by growing investments in biotechnology and the adoption of advanced immunoassay technologies. The innovation landscape is evolving rapidly, with a focus on enhancing antibody specificity and reducing cross-reactivity through recombinant engineering. Demand–supply balance appears stable globally, though supply chain disruptions in emerging markets pose localized challenges. Key risk factors include stringent regulatory requirements, patent expirations, and the high cost of next-generation antibody development. Strategic partnerships and vertical integration are critical for mitigating risks and sustaining growth in this dynamic sector.

12 items

1. Executive Summary

2. Aspartate Aminotransferase Antibody Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Aspartate Aminotransferase Antibody Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Aspartate Aminotransferase Antibody Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Aspartate Aminotransferase Antibody Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Aspartate Aminotransferase Antibody Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Aspartate Aminotransferase Antibody Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Aspartate Aminotransferase Antibody Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Aspartate Aminotransferase Antibody Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Aspartate Aminotransferase Antibody Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Aspartate Aminotransferase Antibody Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Aspartate Aminotransferase Antibody Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Aspartate Aminotransferase Antibody Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Aspartate Aminotransferase Antibody Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Aspartate Aminotransferase Antibody Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Aspartate Aminotransferase Antibody Market Competition by Key Manufacturers

9.1. Global Aspartate Aminotransferase Antibody Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Aspartate Aminotransferase Antibody: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Sino Biological,Inc.

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Cell Signaling Technology,Inc.

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Bio-Techne

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. OriGene Technologies,Inc.

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. LifeSpan BioSciences,Inc

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Abbexa

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. MyBiosource,Inc.

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Biorbyt

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Creative Biolabs

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. GeneTex

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. Arigo Biolaboratories Corp.

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

10.12. Assay Genie

10.12.1. Company Basic Information and Sales Area

10.12.2. Main Business/Business Overview

10.12.3. Product Portfolio

10.12.4. Financial

10.12.5. Recent Industry Insights

10.12.6. SWOT Analysis

10.13. RayBiotech,Inc.

10.13.1. Company Basic Information and Sales Area

10.13.2. Main Business/Business Overview

10.13.3. Product Portfolio

10.13.4. Financial

10.13.5. Recent Industry Insights

10.13.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Aspartate Aminotransferase Antibody Market

Figure 4: Global Aspartate Aminotransferase Antibody Market: Drivers

Figure 5: Global Aspartate Aminotransferase Antibody Market: Challenges

Figure 6: Global Aspartate Aminotransferase Antibody Market: Trends

Figure 7: Global Aspartate Aminotransferase Antibody Market: Opportunity

Figure 8: Global Aspartate Aminotransferase Antibody Market: Restraint

Figure 9: Global Aspartate Aminotransferase Antibody Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Aspartate Aminotransferase Antibody Market Value (USD Million) By Region

Figure 19: Global Aspartate Aminotransferase Antibody Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Aspartate Aminotransferase Antibody Market Value (USD Million) By Region

Figure 27: Global Aspartate Aminotransferase Antibody Market Share (%) By: Regions (2032)

Figure 28: Global Aspartate Aminotransferase Antibody Market Volume (K) By Region

Figure 29: Global Aspartate Aminotransferase Antibody Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Aspartate Aminotransferase Antibody Market Value (USD Million) By Region

Figure 37: Global Aspartate Aminotransferase Antibody Market Share (%) By: Regions (2032)

Figure 38: Global Aspartate Aminotransferase Antibody Market Volume (K) By Region

Figure 39: Global Aspartate Aminotransferase Antibody Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

121 items

Table 1: Market Segmentation Analysis

Table 2: Global Aspartate Aminotransferase Antibody Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Aspartate Aminotransferase Antibody Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Aspartate Aminotransferase Antibody Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Aspartate Aminotransferase Antibody Market Value (USD Million) By Region

Table 14: Global Aspartate Aminotransferase Antibody Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Aspartate Aminotransferase Antibody Market Volume (K) By Region

Table 31: Global Aspartate Aminotransferase Antibody Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Aspartate Aminotransferase Antibody Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Aspartate Aminotransferase Antibody Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Aspartate Aminotransferase Antibody Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Sino Biological,Inc. Basic Information And Sales Area

Table 52: Sino Biological,Inc.. Products Portfolio

Table 53: Cell Signaling Technology,Inc. Basic Information And Sales Area

Table 54: Cell Signaling Technology,Inc.. Products Portfolio

Table 55: Bio-Techne Basic Information And Sales Area

Table 56: Bio-Techne. Products Portfolio

Table 57: OriGene Technologies,Inc. Basic Information And Sales Area

Table 58: OriGene Technologies,Inc.. Products Portfolio

Table 59: LifeSpan BioSciences,Inc Basic Information And Sales Area

Table 60: LifeSpan BioSciences,Inc. Products Portfolio

Table 61: Abbexa Basic Information And Sales Area

Table 62: Abbexa. Products Portfolio

Table 63: MyBiosource,Inc. Basic Information And Sales Area

Table 64: MyBiosource,Inc.. Products Portfolio

Table 65: Biorbyt Basic Information And Sales Area

Table 66: Biorbyt. Products Portfolio

Table 67: Creative Biolabs Basic Information And Sales Area

Table 68: Creative Biolabs. Products Portfolio

Table 69: GeneTex Basic Information And Sales Area

Table 70: GeneTex. Products Portfolio

Table 71: Arigo Biolaboratories Corp. Basic Information And Sales Area

Table 72: Arigo Biolaboratories Corp.. Products Portfolio

Table 73: Assay Genie Basic Information And Sales Area

Table 74: Assay Genie. Products Portfolio

Table 75: RayBiotech,Inc. Basic Information And Sales Area

Table 76: RayBiotech,Inc.. Products Portfolio

Table 77: Global Market Value (USD Million) (2025-2032) By Application

Table 78: Global Market Share (%) By Application (2032)

Table 79: Global Market Value (USD Million) (2025-2032) By Types

Table 80: Global Market Share (%) By Types (2032)

Table 81: Global Market Volume (K) (2025-2032) By Application

Table 82: Global Market Share (%) By Application (2032)

Table 83: Global Market Volume (K) (2025-2032) By Types

Table 84: Global Market Share (%) By Types (2032)

Table 85: Global Aspartate Aminotransferase Antibody Market Value (USD Million) By Region

Table 86: Global Aspartate Aminotransferase Antibody Market Share (%) By Region (2025-2032)

Table 87: North America Market Value (USD Million) (2025-2032) By Country

Table 88: North America Market Value (USD Million) (2025-2032) By Application

Table 89: North America Market Value (USD Million) (2025-2032) By Types

Table 90: Europe Market Value (USD Million) (2025-2032) By Country

Table 91: Europe Market Value (USD Million) (2025-2032) By Application

Table 92: Europe Market Value (USD Million) (2025-2032) By Types

Table 93: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 94: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 95: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 96: South America Market Value (USD Million) (2025-2032) By Country

Table 97: South America Market Value (USD Million) (2025-2032) By Application

Table 98: South America Market Value (USD Million) (2025-2032) By Types

Table 99: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 100: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 101: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 102: Global Aspartate Aminotransferase Antibody Market Volume (K) By Region

Table 103: Global Aspartate Aminotransferase Antibody Market Share (%) By Region (2025-2032)

Table 104: North America Market Volume (K) (2025-2032) By Country

Table 105: North America Market Volume (K) (2025-2032) By Application

Table 106: North America Market Volume (K) (2025-2032) By Types

Table 107: Europe Market Volume (K) (2025-2032) By Country

Table 108: Europe Market Volume (K) (2025-2032) By Application

Table 109: Europe Market Volume (K) (2025-2032) By Types

Table 110: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 111: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 112: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 113: South America Market Volume (K) (2025-2032) By Country

Table 114: South America Market Volume (K) (2025-2032) By Application

Table 115: South America Market Volume (K) (2025-2032) By Types

Table 116: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 117: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 118: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 119: Research Programs/Design For This Report

Table 120: Key Data Information From Secondary Sources

Table 121: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Aspartate Aminotransferase Antibody Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	450.00 million
Revenue forecast in 2033	784.82 million
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Sino Biological,Inc.; Cell Signaling Technology,Inc.; Bio-Techne; OriGene Technologies,Inc.; LifeSpan BioSciences,Inc; Abbexa; MyBiosource,Inc.; Biorbyt; Creative Biolabs; GeneTex; Arigo Biolaboratories Corp.; Assay Genie; RayBiotech,Inc.
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options